Vanguard Group Inc Exact Sciences Corp Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Vanguard Group Inc holds 17,808,477 shares of EXAS stock, worth $1.19 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares
17,808,477
Previous 17,907,459 0.55%
Holding current value
$1.19 Billion
Previous $952 Million 2.39%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$40.91 - $56.0 $4.05 Million - $5.54 Million
-98,982 Reduced 0.55%
17,808,477 $974 Million
Q2 2025

Aug 11, 2025
BUY
$40.31 - $58.08 $10.9 Million - $15.7 Million
269,785 Added 1.53%
17,907,459 $952 Million
Q1 2025

May 09, 2025
BUY
$43.04 - $58.51 $26.6 Million - $36.1 Million
617,384 Added 3.63%
17,637,674 $764 Million
Q4 2024

Feb 11, 2025
SELL
$49.33 - $71.97 $36.7 Million - $53.5 Million
-743,624 Reduced 4.19%
17,020,290 $956 Million
Q3 2024

Nov 13, 2024
SELL
$42.43 - $70.83 $17.5 Million - $29.1 Million
-411,357 Reduced 2.26%
17,763,914 $1.21 Billion
Q2 2024

Aug 13, 2024
BUY
$41.33 - $74.26 $18 Million - $32.3 Million
435,179 Added 2.45%
18,175,271 $768 Million
Q1 2024

May 10, 2024
BUY
$56.27 - $73.77 $10.1 Million - $13.3 Million
180,341 Added 1.03%
17,740,092 $1.23 Billion
Q4 2023

Feb 14, 2024
BUY
$59.06 - $75.72 $6.8 Million - $8.71 Million
115,058 Added 0.66%
17,559,751 $1.3 Billion
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $7.89 Million - $11.8 Million
-119,581 Reduced 0.68%
17,444,693 $1.19 Billion
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $10.8 Million - $16.3 Million
171,986 Added 0.99%
17,564,274 $1.65 Billion
Q1 2023

May 15, 2023
BUY
$47.19 - $70.77 $6.6 Million - $9.9 Million
139,823 Added 0.81%
17,392,288 $1.18 Billion
Q4 2022

Feb 10, 2023
BUY
$30.35 - $53.15 $17.5 Million - $30.6 Million
575,854 Added 3.45%
17,252,465 $854 Million
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $22.3 Million - $34.5 Million
698,740 Added 4.37%
16,676,611 $542 Million
Q2 2022

Aug 12, 2022
BUY
$35.61 - $76.23 $12 Million - $25.6 Million
335,877 Added 2.15%
15,977,871 $629 Million
Q1 2022

May 13, 2022
BUY
$57.56 - $82.54 $12.1 Million - $17.4 Million
210,260 Added 1.36%
15,641,994 $1.09 Billion
Q4 2021

Feb 14, 2022
BUY
$72.5 - $100.68 $4.69 Million - $6.51 Million
64,700 Added 0.42%
15,431,734 $1.2 Billion
Q3 2021

Nov 12, 2021
SELL
$90.24 - $124.05 $3.93 Million - $5.4 Million
-43,521 Reduced 0.28%
15,367,034 $1.47 Billion
Q2 2021

Aug 13, 2021
BUY
$93.66 - $139.27 $1.44 Billion - $2.15 Billion
15,410,555 New
15,410,555 $1.92 Billion

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
164M
Call Options Held
2.21M
Put Options Held
1.69M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email